Evidence map›Paper›PMID 39021194›Full record

ArticleCurrent cardiology reviews2024

Cardiac Amyloidosis in Venezuela: A Pending Issue.

Juan Salazar, Mayela Bracho, Carlos Esis, Roberto Añez-Ramos

Abstract readEditorial
In one paragraph

Article in Current cardiology reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Juan SalazarInstitute for the Research of Cardiovascular Diseases of the University of Zulia, Maracaibo 4004, Venezuela.
Mayela BrachoInstitute for the Research of Cardiovascular Diseases of the University of Zulia, Maracaibo 4004, Venezuela.
Carlos EsisInstitute for the Research of Cardiovascular Diseases of the University of Zulia, Maracaibo 4004, Venezuela.
Roberto Añez-RamosDepartment of Endocrinology and Nutrition, Quirónsalud Hospital, Madrid 28009, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac amyloidosis (CA) is an infiltrative disease characterized by the deposition of misfolded proteins in cardiac interstitial tissue. Interest towards studying this pathology has been growing in the last decade, as new epidemiological insights have revealed that it is not as uncommon as previously believed. Likewise, advances in non-invasive diagnostic approaches and the identification of molecules that modify its long-term progression, even in terms of mortality, have also bolstered interest in CA. Despite this global panorama, in Venezuela, limitations remain regarding the diagnosis of CA, partly associated with a lack of knowledge of the disease. Therefore, additional efforts are necessary for clinical cardiologists to hone their diagnostic skills regarding this disease, as opportune identification is an essential step for its effective management.

Indexed as

AmyloidosisCardiomyopathiesHumansVenezuelaCardiac amyloidosiscardiomyopathy.diagnosisepidemiologymisfolded proteinspathologytreatmentvenezuela

Identifiers

PMID39021194
PMCPMC11440325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.